Elvitegravir is an antiretroviral medication used to treat HIV infection. It belongs to a class of drugs called integrase inhibitors, which work by blocking the integration of viral DNA into the host cell's genome. This helps to prevent the virus from replicating and spreading in the body. Typically, Elvitegravir is combined with other medications in a single tablet regimen to enhance its effectiveness and improve adherence to treatment. It is usually taken once daily with food. Regular monitoring by a healthcare provider is essential to ensure the medication is working effectively and to manage any potential side effects.